Dr. Mark S. Pascal, MD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- Jefferson Medical College of Thomas Jefferson University (1973)
- Years since graduation
- 53
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 532
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1973Medical school: Jefferson Medical College of Thomas Jefferson University
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
NJ license 25MA03545200 -
Hematology (Internal Medicine) Physician
NJ license 25MA03545200
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hackensack University Medical Center Hackensack, NJ
Medical groups
- Regional Cancer Care Associates LLC (151 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 532
- Services billed
- 14,970
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 15,200 | 33 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,013 | 253 |
| Established patient office or other outpatient visit, 20-29 minutes | 352 | 148 |
| Injection of drug or substance under skin or into muscle | 317 | 37 |
| Established patient office or other outpatient visit, 40-54 minutes | 295 | 171 |
| New patient office or other outpatient visit, 45-59 minutes | 59 | 59 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 13 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydroxyurea Other prescribers in Hackensack, NJ | 73 |
| Eliquis (apixaban) Other prescribers in Hackensack, NJ | 23 |
| Anagrelide Hcl | 20 |
| Promacta (eltrombopag olamine) | 17 |
| Warfarin Sodium Other prescribers in Hackensack, NJ | 13 |
| Besremi (ropeginterferon alfa-2b-njft) | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 57 payments worth $1,134 in total to this clinician.
| Alexion Pharmaceuticals, Inc. | $181 |
|---|---|
| Incyte Corporation | $172 |
| Daiichi Sankyo Inc. | $148 |
| Recordati_rare_diseases_inc. | $74.55 |
| E.r. Squibb & Sons, L.l.c. | $63.41 |
| Novartis Pharmaceuticals Corporation | $57.69 |
| Beone Medicines USA, Inc. | $55.27 |
| Merck Sharp & Dohme LLC | $54.15 |
| Food and Beverage | $1,035 |
|---|---|
| Education | $99.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Incyte Corporation Aug 4, 2025 | Education | $99.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.